Note this line all.....as alluded to they can sub licence out and don't need to build a manufacturing site. I would expect to see similar for distribution..
Botanix has also restructured its internal regulatory and quality organization to support
organizational readiness for FDA inspections at the Company, clinical sites and manufacturing
partners following the NDA filing for Sofpironium Bromide
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-101
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |